BRAF and melanoma: Of interest, our preliminary data also suggest that the site of mutation may be important, since the subgroup with V600K BRAF mutation (as opposed to V600E) was associated with more brain metastases, and shorter time for both disease-free and overall survival from diagnosis in melanoma.